ARVO 2025: The early adoption and utilization of perfluorohexoloctane (Miebo)

Published on May 27, 2025
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Continue reading on website
Other news

Clinical trial Q&A: New data on DOT lenses show strong global performance in myopia control

May 27, 2025
New data from North American and Chinese clinical trials reinforce the safety, efficacy, and durability of DOT lenses in slowing pediatric myopia progression, without evidence of rebound.

Driving in the Dark: Fuchs’ Patients Have Reduced Nighttime Vision Despite Normal VA

May 28, 2025
Using the National Advanced Driving Simulator, a small study showed that patients with Fuchs’ dystrophy had shorter hazard detection distances under glare conditions (i.e., headlights) than controls without the disease. Photo: Christine Sindt, OD. Click image to enlarge. As one of the many daily activities affected by Fuchs’ endothelial corneal dystrophy (FECD), patients may